Date post: | 05-Jul-2018 |
Category: |
Documents |
Upload: | shyam-sunder |
View: | 217 times |
Download: | 0 times |
of 5
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
1/5
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
2/5
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
3/5
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
4/5
8/15/2019 Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting [Company Update]
5/5